Mark E Lustberg MD
Instructor, Internal Medicine, Ohio State University College of Medicine
Join to view full profile
20 York StNew Haven, CT 06510
Phone+1 203-688-5523
Fax+1 203-688-3216
Dr. Lustberg is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Ohio State University HospitalFellowship, Infectious Disease, 2007 - 2009
Wellspan Health/York HospitalResidency, Internal Medicine, 2004 - 2007
University of Maryland School of MedicineClass of 2004
Certifications & Licensure
CT State Medical License 2021 - 2027
OH State Medical License 2007 - 2022
PA State Medical License 2004 - 2007
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- 3 citationsEpigenetic activation of EBV BGLF4 determines antiviral-based regimen response in EBV+CNS lymphoproliferative disease.Christoph Weigel, Haley L Klimaszewski, Fode Tounkara, Selamawit Addissie, Sarah Schlotter
Blood Neoplasia. 2026-05-01 - 3 citationsAnti-IL-5 Treatment Reduces Infection-Related Adverse Events: A Meta-Analysis of Phase 3 Clinical Trials.Mark E Lustberg, Brian Clark
The Journal of Allergy and Clinical Immunology. in Practice. 2025-07-01 - 1 citationsClinical outcomes in patients with mild to moderate coronavirus disease 2019 treated with monoclonal antibody therapy versus an untreated control cohort.Courtney N Nichols, Mark Lustberg, Mohammed Mahdee E Sobhanie, Lucia J Niermann, Melissa Gordon
Antiviral Therapy. 2024-08-01
Press Mentions
Unique Oral Presentations of Deep Fungal Infections: A Report of Four CasesSeptember 5th, 2020
Grant Support
- ENOS And The Blood Lead-Blood Pressure RelationshipNational Institute Of Environmental Health Sciences2000–2003
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: